Avantor/$AVTR
1D1W1MYTD1Y5YMAX
Capital at risk
About Avantor
Avantor Inc provides products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company operates through two segments: Laboratory Solutions and Bioscience Production. It offers materials & consumables, equipment & instrumentation, and services & specialty procurement. Product groups include Equipment & Instrumentation, Services & Specialty Procurement, Proprietary Materials & Consumables, and Third-Party Materials & Consumables. Materials & consumables include high-purity chemicals and reagents, lab supplies, customized excipients, single-use assemblies, chromatography products, sample preparation kits, and fluid handling solutions. It operates in the Americas, Europe, and AMEA.
- Ticker
- $AVTR
- Sector
- Health
- Primary listing
- NYSE
- Employees
- 13,500
- Headquarters
- Radnor, United States
- Website
- www.avantorsciences.com
Avantor Metrics
BasicAdvanced
$10B
-
-$0.85
0.89
-
Price and volume
Market cap
$10B
Beta
0.89
52-week high
$15.93
52-week low
$7.27
Average daily volume
9.2M
Financial strength
Current ratio
1.782
Quick ratio
1.046
Long term debt to equity
65.021
Total debt to equity
65.678
Interest coverage (TTM)
2.39%
Profitability
EBITDA (TTM)
943.7
Gross margin (TTM)
31.83%
Net profit margin (TTM)
-8.81%
Operating margin (TTM)
8.01%
Effective tax rate (TTM)
-22.46%
Revenue per employee (TTM)
$490,000
Management effectiveness
Return on assets (TTM)
2.70%
Return on equity (TTM)
-9.70%
Valuation
Price to revenue (TTM)
1.576
Price to book
1.83
Price to tangible book (TTM)
-4.45
Price to free cash flow (TTM)
22.736
Free cash flow yield (TTM)
4.40%
Free cash flow per share (TTM)
0.671
Growth
Revenue change (TTM)
-1.57%
Earnings per share change (TTM)
-184.64%
3-year revenue growth (CAGR)
-2.94%
3-year earnings per share growth (CAGR)
10.97%
What the Analysts think about Avantor
Analyst ratings (Buy, Hold, Sell) for Avantor stock.
Analyst projections of the future price of Avantor stock.
Bulls say / Bears say
Avantor beat Wall Street Q2 2026 expectations, delivering adjusted EPS of $0.21 versus the $0.19 consensus and revenue of $1.69 billion versus $1.61 billion forecast, driving shares up over 15% in premarket trading. (Investing.com)
The company raised its full-year 2026 organic revenue growth guidance range to –0.5% to +0.5% and lifted adjusted EPS guidance to $0.80–$0.83, reflecting management’s confidence in its Revival turnaround program. (StockTitan)
Avantor generated robust free cash flow in Q2, using $142.8 million of free cash flow to repay $112.1 million of debt in the quarter and nearly $500 million over the past 12 months, underscoring improving balance-sheet resilience. (MarketBeat)
Reported sales of $1.69 billion in Q2 2026 were essentially flat year-on-year, underscoring ongoing demand challenges. (Yahoo Finance)
GAAP net income for Q2 2026 fell to $38.1 million from $64.7 million a year earlier, compressing net margin to just 2.3%. (Stockwatch)
As of June 30, 2026, Avantor’s gross debt stood at $3.715 billion against cash of $306.8 million, keeping leverage elevated and limiting financial flexibility. (Morningstar)
Data summarised monthly by Lightyear AI. Last updated on 25 Aug 2026.
Avantor Financial Performance
Revenues and expenses
Avantor Earnings Performance
Company profitability
Upcoming events
No upcoming events
Avantor News
AllArticlesVideos
Funds containing Avantor
AllUSDGBPEUR
Fund name | Fund size | $AVTR weighting |
|---|---|---|
SPDR S&P 400 US Mid Cap$SPY4 | $6.3B | 0.28% |
SPDR S&P 400 US Mid Cap£SPX4 | £4.7B | 0.28% |
iShares MSCI USA Small Cap ESG Enhanced CTB€SXRG | €2.8B | 0.16% |
iShares MSCI USA Small Cap CTB Enhanced ESG£CUS1 | £2.4B | 0.16% |
iShares MSCI World Small Cap$WSML | $9B | 0.08% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.